Source: Annual Congress 2009 - From cough to sound analysis of breathing
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Pfnuer, M. Boensch, S. Winterkamp, J. Behr, K. Kenn (Schoenau am Koenigssee, Munich, Germany). The potential role of exhaled no and FEV1 as diagnostic parameters in vocal cord dysfunction (VCD). Eur Respir J 2009; 34: Suppl. 53, 249

Member's Comments

No comment yet.

Related content which might interest you: Why should we perform lung function tests? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007 Monitoring of pediatric asthma by symptoms and lung function versus symptoms, lung function and exhaled NO Source: Annual Congress 2004 - Monitoring childhood asthma Year: 2004 The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma. Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace Source: Eur Respir J 2006; 27: 374-377 Year: 2006 Relationship between pre-bronchodilator FEV1 and ex-vivo intrinsic tone in human small airways Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Lung function measurement in respiratory diseases: mechanisms Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease Year: 2006 The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Validity of FENO and small airway function indices in diagnosis of CVA. Source: International Congress 2017 – Management of asthma in different situations Year: 2017 Impulse oscillometry assessment of small airway dysfunction pre- and post-bronchodilator in asthma and its relationship to disease severity Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014 The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002 Auscultatory forced expiratory time as a predictor of FEV1 and as a clinical test of airway obstruction Source: Eur Respir J 2004; 24: Suppl. 48, 225s Year: 2004 Airway hyperresponsiveness, but not exhaled nitric oxide, as a risk factor for decline in post-bronchodilator FEV1 in patients with stable asthma Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008 Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma Source: Eur Respir J 2009; 34: 574 Year: 2009 Basic principles of lung mechanics Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease Year: 2006 Asthma control test (ACT), fractionated exhaled nitric oxide (FeNO) and forced expiratory volume in 1 second (FEV1) correlation in asthma control Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012